Lazard Asset Management’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,568
Closed -$49K 2616
2022
Q2
$49K Sell
3,568
-220,761
-98% -$3.11M ﹤0.01% 1824
2022
Q1
$4.07M Buy
224,329
+224,118
+106,217% +$3.21M ﹤0.01% 788
2021
Q4
$3K Buy
+211
New +$3.27K ﹤0.01% 2207

Other funds holding SGFY

Lazard Asset Management's SGFY Position: Q3 2022 in Review

Lazard Asset Management sold out of Signify Health, Inc. (SGFY) in Q3 2022, closing a stake of 3,568 shares — an estimated $49K sold.

Lazard Asset Management first reported a position in SGFY in Q4 2021 and held it in 3 quarters. The position peaked at $4.07M in Q1 2022. 205 funds tracked by Wall St. Rank hold SGFY as of Q3 2022.

  • Lazard Asset Management reported no remaining Signify Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 3,568 Signify Health, Inc. shares in Q3 2022, an estimated $49K.
  • Lazard Asset Management first reported a position in Signify Health, Inc. in Q4 2021 and held it in 3 quarters.
  • Lazard Asset Management's Signify Health, Inc. position peaked at $4.07M in Q1 2022.
  • 205 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.